112 related articles for article (PubMed ID: 20553760)
1. Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease.
Gormaz JG; Rodrigo R; Videla LA; Beems M
Prog Lipid Res; 2010 Oct; 49(4):407-19. PubMed ID: 20553760
[TBL] [Abstract][Full Text] [Related]
2. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: Relation to LCPUFA depletion in liver and extrahepatic tissues.
Valenzuela R; Barrera C; Espinosa A; Llanos P; Orellana P; Videla LA
Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():7-14. PubMed ID: 25910408
[TBL] [Abstract][Full Text] [Related]
5. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients.
Araya J; Rodrigo R; Pettinelli P; Araya AV; Poniachik J; Videla LA
Obesity (Silver Spring); 2010 Jul; 18(7):1460-3. PubMed ID: 19875987
[TBL] [Abstract][Full Text] [Related]
6. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
[TBL] [Abstract][Full Text] [Related]
7. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
López-Vicario C; González-Périz A; Rius B; Morán-Salvador E; García-Alonso V; Lozano JJ; Bataller R; Cofán M; Kang JX; Arroyo V; Clària J; Titos E
Gut; 2014 Feb; 63(2):344-55. PubMed ID: 23492103
[TBL] [Abstract][Full Text] [Related]
8. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of non-alcoholic fatty liver disease.
Bellentani S; Scaglioni F; Marino M; Bedogni G
Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
[TBL] [Abstract][Full Text] [Related]
12. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
Elizondo A; Araya J; Rodrigo R; Poniachik J; Csendes A; Maluenda F; Díaz JC; Signorini C; Sgherri C; Comporti M; Videla LA
Obesity (Silver Spring); 2007 Jan; 15(1):24-31. PubMed ID: 17228028
[TBL] [Abstract][Full Text] [Related]
13. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
14. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
Petta S; Muratore C; Craxì A
Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
[TBL] [Abstract][Full Text] [Related]
17. Fatty liver: role of inflammation and fatty acid nutrition.
Byrne CD
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787
[TBL] [Abstract][Full Text] [Related]
18. Effect of diets enriched in Delta6 desaturated fatty acids (18:3n-6 and 18:4n-3), on growth, fatty acid composition and highly unsaturated fatty acid synthesis in two populations of Arctic charr (Salvelinus alpinus L.).
Tocher DR; Dick JR; MacGlaughlin P; Bell JG
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jun; 144(2):245-53. PubMed ID: 16630735
[TBL] [Abstract][Full Text] [Related]
19. Characterization and comparison of fatty acyl Delta6 desaturase cDNAs from freshwater and marine teleost fish species.
Zheng X; Seiliez I; Hastings N; Tocher DR; Panserat S; Dickson CA; Bergot P; Teale AJ
Comp Biochem Physiol B Biochem Mol Biol; 2004 Oct; 139(2):269-79. PubMed ID: 15465674
[TBL] [Abstract][Full Text] [Related]
20. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
